Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Deferred Income Tax Assets, Net in USD for Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Deferred Income Tax Assets, Net history and growth rate for Q4 2023.
  • Cordyceps Sunshine Biotech Holdings Co., Ltd. Deferred Income Tax Assets, Net for the quarter ending December 31, 2023 was $42.8K.
Deferred Income Tax Assets, Net, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $42.8K Dec 31, 2023 20-F 2024-07-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.